# CHemotherapy and Stool Transplant in PDAC (CHASe-PDAC)

> **NCT06393400** · PHASE1 · RECRUITING · sponsor: **John Lenehan** · enrollment: 20 (estimated)

## Conditions studied

- Unresectable or Metastatic Advanced Pancreatic Ductal Adenocarcinoma

## Interventions

- **DRUG:** Fecal Microbiota Transplantation
- **DRUG:** PEG3350
- **DRUG:** Gemcitabine
- **DRUG:** nab-Paclitaxel

## Key facts

- **NCT ID:** NCT06393400
- **Lead sponsor:** John Lenehan
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-08
- **Primary completion:** 2028-02
- **Final completion:** 2028-02
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2025-01-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06393400

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06393400, "CHemotherapy and Stool Transplant in PDAC (CHASe-PDAC)". Retrieved via AI Analytics 2026-09-07 from https://api.ai-analytics.org/clinical/NCT06393400. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*